EGFR and colorectal carcinoma: In this study, we identified a glucose-free, high-protein diet (GFHPD) to prevent high glycolysis activity while boosting amino acid metabolism, thereby reducing CRC burden with similar efficacy as EGFR-directed antibody therapy in an experimental mouse model of colitis-driven CRC.